The 2026 oral probiotic and topical secretome protocol will not change acne care yet because it tests an idea without reporting results. Secretome means the signaling mixture collected from cultured stem cells, applied here as a topical add-on. Adults with persistent acne therefore gain no new treatment choice from this publication.
Probiotics target gut bacteria, while secretome targets skin inflammation. The plan combines both with standard prescription cream. Readers can use the design details to avoid premature spending and keep effective care.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What the trial will test
- Who is included and what is measured
- Why 64 patients over 8 weeks cannot settle care
- What adults with persistent acne should do now
What the trial will test
The plan randomizes 64 patients with mild-to-moderate acne into four treatment arms for 8 weeks. The U.S. National Library of Medicine PubMed record describes the four-way mix of active and placebo probiotic plus active and placebo secretome the PubMed trial record.
Every arm adds the experimental products to standard care. All participants apply a standard night cream with clindamycin and tretinoin to acne areas. BMJ Open states that the oral product is HEXBIO granules with six Lactobacillus and Bifidobacterium strains the published protocol. This structure isolates any added effect from the base prescription.
Who is included and what is measured
The protocol focuses on adolescents and adults with mild-to-moderate acne eligible at the Indonesian trial site. It uses pretest and posttest checks of acne severity, fecal microbiome, skin condition, and inflammation measures. These outcomes link gut changes, skin changes, and visible acne together.
The protocol was approved by the Health Research Ethics Committee of Bali Mandara Regional Hospital and follows Helsinki and good clinical practice principles. That approval covers trial conduct, not treatment approval. Results, if published later, would apply first to similar mild-to-moderate cases.
Why 64 patients over 8 weeks cannot settle care
BMJ Open lists small sample size as a limitation because 64 participants reduce power to detect smaller effects. An 8-week intervention also cannot show long-term benefit, sustained clearance, or relapse after stopping. Adults with persistent acne often need months of maintenance and relapse data.
A protocol also cannot establish dose, product consistency, or safety for routine use. Topical secretome methods still face manufacturing and standardization questions. Larger and longer trials must follow before guidelines change.
What adults with persistent acne should do now
American Academy of Dermatology guidance reported via Newswise strongly recommends benzoyl peroxide, topical retinoids, antibiotics, and selected combinations the Academy guidance summary. Adults with persistent acne should continue those proven regimens while new data develop.
Stopping an effective prescription for an unproven add-on risks flare and scarring. An International Journal of Dermatology review reports that no mesenchymal stem cell-derived secretome or exosome product has FDA or EMA approval for dermatologic use the dermatology review. That status reflects unresolved standardization, manufacturing, and safety questions for topical secretome approaches.
- Keep using the prescribed retinoid, benzoyl peroxide, or antibiotic combination as directed.
- Track breakouts, irritation, missed doses, and menstrual or stress patterns for 4 to 8 weeks.
- Ask a dermatologist before adding probiotic, secretome, or exosome products sold online.
- Bring a list of current prescriptions and over-the-counter products to your next dermatology visit for review.
You Might Also Like
- Skin Microbiome Outcomes in the 2026 Probiotic Acne Review: Why the Findings May Not Change Acne Care Yet for Adults With Persistent Acne
- The 2026 Oral Probiotic and Topical Secretome Acne Trial Protocol: Safety and Skin-Reaction Questions for Adults With Persistent Acne
- Probiotics for Acne in a 2026 Systematic Review and Meta-Analysis: Why the Findings May Not Change Acne Care Yet for Adults With Persistent Acne